Matt Davis

Matt Davis

Company: Gritstone Bio

Job title: Director of NGS


Evaluating Neoantigen Immunotherapies in the Clinic 12:30 pm

Utilizing advances in genomic analysis and interpretation for therapeutic development Selection of therapeutically useful neoantigens for immunization Integrating immune monitoring and cell free DNA (cfDNA) to evaluate immunotherapies clinicallyRead more

day: Track B - Day 2 AM

Panel Discussion: What’s Needed to Move the Needle in IO? 1:00 pm

Overcoming heterogeneity and resistance mechanisms – can technology approaches intelligently investigate this? Discussing the utility of larger panels to better unpick disease drivers and identify predictive biomarkers Validating biomarkers in a crowded market What tools, such as computational pathology, can enable early biomarker decisions to influence downstream clinical success?Read more

day: Track A - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.